Copper sulfate
VARIOUS
Also known as: copper sulfate pentahydrate, cupric sulfate, cupric sulfate anhydrous, cupric sulfate pentahydrate
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Copper sulfate is a drug catalogued in DrugCentral. It was first approved by the FDA in 1987.
- ATC code: V03AB20 (Antidotes).
- Molecular formula: CuO4S; molecular weight 159.60 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Contraindications (2)
- Hypocupremia
- Wilson's disease
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1987-05-05 | FDA | — | ABRAXIS PHARM |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
V03AB20 | VARIOUS › ALL OTHER THERAPEUTIC PRODUCTS › ALL OTHER THERAPEUTIC PRODUCTS › Antidotes |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Off label use | 266.3 |
| Product use in unapproved indication | 210.3 |
| Synovitis | 168.9 |
| Product dose omission issue | 160.4 |
| Contraindicated product administered | 158.5 |
| Diarrhoea | 153.5 |
| Systemic lupus erythematosus | 145.1 |
| Treatment failure | 137.7 |
| Maternal exposure during pregnancy | 129.8 |
| Glossodynia | 122.8 |
| Infusion related reaction | 119.8 |
| Fatigue | 119.3 |
Chemical structure
| Molecular formula | CuO4S |
|---|---|
| Molecular weight | 159.60 g/mol |
| CAS number | 7758-99-8 |
| InChIKey | — |
| PubChem CID | 24462 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
When was Copper sulfate first approved?
Copper sulfate was first approved by the FDA in 1987.
What is the chemical formula of Copper sulfate?
Copper sulfate has the molecular formula CuO4S and a molecular weight of 159.60 g/mol.
Browse: all drugs starting with C · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 4282 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL604 — compound record and bioactivity
- PubChem CID 24462 — chemical identifiers
- DrugBank DB06778 — drug record
- FDA UNII LRX7AJ16DT — substance identity
- DailyMed: FDA labels for Copper sulfate — current prescribing information (label search)
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.